Main Industry
Biotechnology
Main Product/Service
Ovarian Cancer Biological Research and HPV Vaccine
The content above was translated by Ai
Founded Year
2012
Unified Business No.
53932410
Status
Active
Number of Employees
0
Total Paid-in
Capital
37,589,870 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
In 2012, ONCOLOCK CORP. was established in Taipei to explore tumor markers in the blood. In 2017, we successfully developed a next-generation ovarian cancer biomarker code-named "OLOV-1" and filed a patent application in September 2017.
The content above was translated by Ai
